ABD Gda ve la Dairesi (FDA), bu tr risklere dikkat ekerek rn etiketlerinde gncellemeler yaplmasn istemitir (3)
Strengths: Only semaglutide product Health Canada-approved for weight management Highest dose (2.4 mg) delivers the strongest average weight loss about 15% body weight over 68 weeks in STEP 1 [4] SELECT trial demonstrated 20% reduction in major adverse cardiovascular events [2] Five-step titration schedule helps manage GI side effects Limitations: Insurance coverage for weight management is inconsistent across provinces and private plans Higher dose means higher rates of nausea, vomiting and diarrhea during titration Out-of-pocket cost is roughly $380$500 per month [5] Read our Wegovy guide for titration tips and coverage advice

For type 2 diabetes, your options include: DPP-4 inhibitors GLP-1 receptor agonists (Ozempic, Trulicity, Victoza) GLP-1/GIP receptor agonists (Mounjaro) SGLT2 inhibitors Thiazolidinediones And prescription weight-loss medications that are currently available include: Orforglipron, an oral small-molecule non-peptide GLP-1 receptor agonist ( Foundayo ) GLP-1/GIP receptor agonists ( Zepbound ) Phentermine-topiramate ( Qsymia ) Bupropion-naltrexone ( Contrave ) Your clinician, like those through Weight Watchers Med+ , can go over your available options and, if you qualify, prescribe medication and a lifestyle plan designed for your body and your goals.* Retatrutide warnings and precautions Despite the fact that retatrutide is not an approved medication, there is active marketing for medications being characterized as retatrutide. Because retatrutide is still investigational, there is no regulated manufacturing or supply chain, meaning you cannot be sure what you are actually receiving and putting in your body, says Rhodes

First, remember the long term time-frame of the cost